Receptor-coupled, DAG-gated Ca2+-permeable cationic channels in LNCaP human prostate cancer epithelial cells.

V Sydorenko, Y Shuba, S Thebault, M Roudbaraki, G Lepage, N Prevarskaya, R Skryma
Author Information
  1. V Sydorenko: Laboratoire de Physiologie Cellulaire, INSERM EMI 0228, Bâtiment SN3, USTL, 59655 Villeneuve d'Ascq, France.

Abstract

Although the prostate gland is a rich source of alpha1-adreno- (alpha1-AR) and m1-cholino receptors (m1-AChR), the membrane processes associated with their activation in glandular epithelial cells is poorly understood. We used the whole-cell patch-clamp technique to show that the agonists of the respective receptors, phenylephrine (PHE) and carbachol (CCh), activate cationic membrane currents in lymph node carcinoma of the prostate (LNCaP) human prostate cancer epithelial cells, which are not dependent on the filling status of intracellular IP3-sensitive Ca2+ stores, but directly gated by diacylglycerol (DAG), as evidenced by the ability of its membrane permeable analogue, OAG, to mimic the effects of the agonists. The underlying cationic channels are characterized by the weak field-strength Eisenman IV permeability sequence for monovalent cations (PK(25) > PCs(4.6) > PLi(1.4) > PNa(1.0)), and the following permeability sequence for divalent cations: PCa(1.0) > PMg(0.74) > PBa(0.6) > PSr(0.36) > PMn(0.3). They are 4.3 times more permeable to Ca2+ than Na+ and more sensitive to the inhibitor 2-APB than SK&F 96365. RT-PCR analysis shows that DAG-gated members of the transient receptor potential (TRP) channel family, including TRPC1 and TRPC3, are present in LNCaP cells. We conclude that, in prostate cancer epithelial cells, alpha1-ARs and m1-AChRs are functionally coupled to Ca2+-permeable DAG-gated cationic channels, for which TRPC1 and TRPC3 are the most likely candidates.

References

  1. Am J Physiol Cell Physiol. 2000 Mar;278(3):C526-36 [PMID: 10712241]
  2. J Biol Chem. 1999 Sep 24;274(39):27359-70 [PMID: 10488066]
  3. Circ Res. 2001 Feb 16;88(3):325-32 [PMID: 11179201]
  4. J Biol Chem. 2001 Jan 12;276(2):1063-70 [PMID: 11042187]
  5. J Auton Pharmacol. 2000 Aug;20(4):193-206 [PMID: 11260358]
  6. J Biol Chem. 2001 Apr 20;276(16):13331-9 [PMID: 11278449]
  7. Cancer Res. 2001 May 1;61(9):3760-9 [PMID: 11325849]
  8. J Biol Chem. 2001 Jun 1;276(22):19461-8 [PMID: 11278579]
  9. Nature. 2001 May 31;411(6837):595-9 [PMID: 11385575]
  10. Nat Rev Neurosci. 2001 Jun;2(6):387-96 [PMID: 11389472]
  11. J Biol Chem. 2001 Jun 15;276(24):21303-10 [PMID: 11290752]
  12. Biochem Biophys Res Commun. 2001 Apr 6;282(3):729-34 [PMID: 11401523]
  13. FASEB J. 2001 Aug;15(10):1727-38 [PMID: 11481220]
  14. Biochem J. 2001 Sep 15;358(Pt 3):717-26 [PMID: 11535132]
  15. Proc Natl Acad Sci U S A. 2001 Sep 25;98(20):11777-82 [PMID: 11553786]
  16. Br J Pharmacol. 2001 Oct;134(3):453-62 [PMID: 11588099]
  17. Cell Calcium. 2001 Nov;30(5):323-9 [PMID: 11733938]
  18. J Biol Chem. 2001 Dec 21;276(51):47767-70 [PMID: 11687570]
  19. Endocrinology. 1999 Oct;140(10):4874-85 [PMID: 10499547]
  20. Prostate. 2002 Jan 1;50(1):15-26 [PMID: 11757032]
  21. Cancer Lett. 2002 Feb 8;176(1):57-63 [PMID: 11790454]
  22. J Biol Chem. 2002 Apr 19;277(16):13569-77 [PMID: 11827975]
  23. Prog Neurobiol. 2002 Mar;66(4):243-64 [PMID: 11960680]
  24. Pharmacol Ther. 2002 Apr-May;94(1-2):93-112 [PMID: 12191596]
  25. Cancer Res. 1983 Apr;43(4):1809-18 [PMID: 6831420]
  26. Rev Physiol Biochem Pharmacol. 1988;111:117-224 [PMID: 2906170]
  27. Biochem J. 1990 Oct 15;271(2):515-22 [PMID: 2173565]
  28. J Biol Chem. 1992 Dec 25;267(36):25798-802 [PMID: 1334487]
  29. J Urol. 1993 Aug;150(2 Pt 1):546-51 [PMID: 7686987]
  30. Pharmacol Ther. 1993 Jun;58(3):319-79 [PMID: 7504306]
  31. Br J Urol. 1994 Nov;74(5):585-9 [PMID: 7530122]
  32. Bioessays. 1995 Jun;17(6):491-500 [PMID: 7575490]
  33. Eur J Pharmacol. 1996 Jan 4;295(1):93-102 [PMID: 8925880]
  34. Life Sci. 1997;60(13-14):963-8 [PMID: 9121362]
  35. Prostate. 1997 May 15;31(3):198-203 [PMID: 9167773]
  36. J Cell Biol. 1997 Sep 22;138(6):1333-41 [PMID: 9298988]
  37. Prostate. 1997 Oct 1;33(2):112-22 [PMID: 9316652]
  38. J Biol Chem. 1998 Jan 2;273(1):133-42 [PMID: 9417057]
  39. Prostate Suppl. 1998;8:2-13 [PMID: 9690657]
  40. Nature. 1998 Oct 15;395(6703):645-8 [PMID: 9790183]
  41. Br J Urol. 1998 Nov;82(5):733-7 [PMID: 9839591]
  42. Nature. 1998 Dec 3;396(6710):478-82 [PMID: 9853757]
  43. J Urol. 1999 Feb;161(2):635-40 [PMID: 9915474]
  44. J Physiol. 1999 Jul 15;518 Pt 2:345-58 [PMID: 10381584]
  45. Eur Urol. 1999;36 Suppl 1:31-4; discussion 65 [PMID: 10393470]
  46. Eur Urol. 1999;36 Suppl 1:42-7; discussion 65 [PMID: 10393472]
  47. Eur J Pharmacol. 1999 Jun 30;375(1-3):261-76 [PMID: 10443582]
  48. J Biol Chem. 2000 Sep 8;275(36):27799-805 [PMID: 10882720]

MeSH Term

Base Sequence
Calcium Channels
Carbachol
DNA Primers
Electrophysiology
Evoked Potentials
Humans
Ion Channels
Male
Phenylephrine
Potassium Channels
Prostatic Neoplasms
Receptors, Adrenergic, alpha-1
Receptors, Muscarinic
Reverse Transcriptase Polymerase Chain Reaction
Ruthenium Red
TRPC Cation Channels
Tetraethylammonium
Tumor Cells, Cultured

Chemicals

Calcium Channels
DNA Primers
Ion Channels
Potassium Channels
Receptors, Adrenergic, alpha-1
Receptors, Muscarinic
TRPC Cation Channels
transient receptor potential cation channel, subfamily C, member 1
Ruthenium Red
Phenylephrine
Tetraethylammonium
Carbachol

Word Cloud

Created with Highcharts 10.0.0>0prostatecellsepithelialcationicmembraneLNCaPcancerchannels41DAG-gatedreceptorsagonistshumanCa2+permeablepermeabilitysequence63TRPC1TRPC3Ca2+-permeableAlthoughglandrichsourcealpha1-adreno-alpha1-ARm1-cholinom1-AChRprocessesassociatedactivationglandularpoorlyunderstoodusedwhole-cellpatch-clamptechniqueshowrespectivephenylephrinePHEcarbacholCChactivatecurrentslymphnodecarcinomadependentfillingstatusintracellularIP3-sensitivestoresdirectlygateddiacylglycerolDAGevidencedabilityanalogueOAGmimiceffectsunderlyingcharacterizedweakfield-strengthEisenmanIVmonovalentcationsPK25PCsPLiPNafollowingdivalentcations:PCaPMg74PBaPSr36PMntimesNa+sensitiveinhibitor2-APBSK&F96365RT-PCRanalysisshowsmemberstransientreceptorpotentialTRPchannelfamilyincludingpresentconcludealpha1-ARsm1-AChRsfunctionallycoupledlikelycandidatesReceptor-coupled

Similar Articles

Cited By